US FDA flags quality lapses at an Indian drug plant, raising import scrutiny concerns and reinforcing the need for strict data integrity and global manufacturing compliance.
Government may lift price cap on key cancer drugs like cisplatin and carboplatin, allowing up to 50% price hike amid raw material surge and supply shortage concerns.
Phox Health Revolutionizes Medicine Delivery in India as the US-based healthcare logistics company officially launches its India operations, marking a significant step in the country's evolving healthcare supply chain sector.
The Central Drugs Standard Control Organisation (CDSCO) has flagged several drug samples linked to some of India’s leading pharmaceutical companies as Not of Standard Quality (NSQ) for April 2026, highlighting ongoing concerns around drug quali...
NPPA may approve price hike for cancer drugs like carboplatin and cisplatin as raw material costs surge, raising supply concerns and impacting oncology treatment access in India.
Explore how myths around blood cancer are debunked with facts on CAR T-cell therapy, early detection, and advanced treatment options improving survival and patient outcomes.
Novelix Pharma jumps 10% after signing a commercial production agreement with Germany’s GMBU to scale Astaxanthin manufacturing, strengthening its pharma capabilities and growth outlook.
Maarga Mind Care has launched an Integrated Maternal Mental Health Programme along with Maarga Divasa, an integrated day care programme aimed at supporting mothers through the emotional and psychological challenges that often come with pregnan...
Lupin Limited and Natco Pharma have received US FDA approval for Eribulin Mesylate Injection, expanding their oncology portfolio and strengthening access to generic cancer treatments in the United States market.
Delhi High Court asks CDSCO to review Zydus semaglutide approval, raising concerns over dosing safety and drug delivery design, with wider implications for India’s fast-growing GLP-1 and diabetes drug market.